What is the current Price Target for the ORIC Pharmaceuticals Inc stock?

The average ORIC Pharmaceuticals Inc target price is $21.42. This is 75.50% higher than the current stock price. The highest price target is 132.28%, the lowest is 15.85%. 14 Analysts have issued a price target ORIC Pharmaceuticals Inc 2027 .

How high will the ORIC Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the ORIC Pharmaceuticals Inc stock will rise. The performance of stocks, including the ORIC Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the ORIC Pharmaceuticals Inc stock today?

The performance of ORIC Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the ORIC Pharmaceuticals Inc stock fall?

The decline in ORIC Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

ORIC Pharmaceuticals Inc Forecast, price target & analysts

$12.21

2.52%

Nasdaq, Oct 02, 04:00 pm EDT. Closed.

ISIN

US68622P1093

Symbol

ORIC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

ORIC Pharmaceuticals Inc Target price 2026 - Analyst rating & recommendation

ORIC Pharmaceuticals Inc Classifications & Recommendation

Buy

90%

Hold

10%

ORIC Pharmaceuticals Inc Price Target

Target Price	$21.42
Price	$12.21
Potential	75.50% register free of charge
Number of Estimates	14

	14 Analysts have issued a price target ORIC Pharmaceuticals Inc 2027 . The average ORIC Pharmaceuticals Inc target price is $21.42. This is 75.50% register free of charge higher than the current stock price. The highest price target is $28.35 132.28% register free of charge , the lowest is $14.14 15.85% register free of charge .
	A rating was issued by 20 analysts: 18 Analysts recommend ORIC Pharmaceuticals Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the ORIC Pharmaceuticals Inc stock has an average upside potential 2027 of 75.50% register free of charge . Most analysts recommend the ORIC Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-1.47	-1.53
	19.67%	4.08%
P/E		negative

16 Analysts have issued a ORIC Pharmaceuticals Inc forecast for earnings per share. The average ORIC Pharmaceuticals Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-1.47	19.67%
2026	$-1.53 4.08% unlock
2027	$-1.69 10.46% unlock
2028	$-1.73 2.37% unlock
2029	$-1.79 3.47% unlock
2030	$-0.67 62.57% unlock
2031	$1.39 307.46% unlock
2032	$2.34 68.35% unlock
2033	$3.60 53.85% unlock

Current	-9.46	48.89%
2026	-7.97 15.76% unlock
2027	-7.24 9.16% unlock
2028	-7.05 2.62% unlock
2029	-6.81 3.40% unlock
2030	-18.13 166.23% unlock
2031	8.76 148.32% unlock
2032	5.23 40.30% unlock
2033	3.39 35.18% unlock

ORIC Pharmaceuticals Inc...

Current ORIC Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
BTIG	Locked ➜ Locked	Locked	Sep 23 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 10 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 08 2026
Citigroup	Locked ➜ Locked	Locked	May 05 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 02 2026
Wedbush	Locked ➜ Locked	Locked	Apr 01 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 13 2026

Analyst Rating	Date
Locked BTIG: Locked ➜ Locked	Sep 23 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 10 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 08 2026
Locked Citigroup: Locked ➜ Locked	May 05 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 02 2026
Locked Wedbush: Locked ➜ Locked	Apr 01 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 13 2026

Discover more stocks with a high price target

NIO ADR 86.90%

Alibaba Group Holding Ltd 81.89%

Rheinmetall 70.55%

Tencent Holdings Ltd. 61.28%

Adyen 56.67%

Uber Technologies 51.26%

BYD 50.30%

Siemens Energy 43.79%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now